Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Turid Aas

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|November 4, 2009
Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor statusJürgen Geisler, Takashi Suzuki, Hildegunn Helle, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 26, 2017
Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study)Karolina Lundstam, Ansgar Heck, Kristin Godang, et al.
Journal of Clinical Pathology|September 11, 2016
Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survivalTor A Klingen, Ying Chen, Ingunn M Stefansson, et al.
Molecular Cancer Therapeutics|November 24, 2006
Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancerTherese Sørlie, Charles M Perou, Cheng Fan, et al.
European Thyroid Journal|July 2, 2019
The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in NorwayElse Marie Opsahl, Lars Andreas Akslen, Ellen Schlichting, et al.
Molecular Cancer|March 27, 2010
DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment responseEmelyne Dejeux, Jo Anders Rønneberg, Hiroko Solvang, et al.
Annals of Internal Medicine|April 18, 2022
Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus ObservationMikkel Pretorius, Karolina Lundstam, Ansgar Heck, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 3, 2023
Positive Effect of Parathyroidectomy Compared to Observation on BMD in a Randomized Controlled Trial of Mild Primary HyperparathyroidismKarolina Lundstam, Mikkel Pretorius, Jens Bollerslev, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 30, 2020
Effects of Parathyroidectomy on Quality of Life: 10 Years of Data From a Prospective Randomized Controlled Trial on Primary Hyperparathyroidism (the SIPH-Study)Mikkel Pretorius, Karolina Lundstam, Mikael Hellström, et al.
Scientific Reports|January 17, 2026
Low tumoral Trefoil Factor 1 expression relates to aggressive tumor features and poor survival in young women with breast cancerAmalie B Kvamme, Ulrikke Hugaas, Anna K M Sæle, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Steroid Biochemistry and Molecular Biology|November 4, 2009
Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor statusJürgen Geisler, Takashi Suzuki, Hildegunn Helle, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 26, 2017
Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study)Karolina Lundstam, Ansgar Heck, Kristin Godang, et al.
Journal of Clinical Pathology|September 11, 2016
Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survivalTor A Klingen, Ying Chen, Ingunn M Stefansson, et al.
Molecular Cancer Therapeutics|November 24, 2006
Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancerTherese Sørlie, Charles M Perou, Cheng Fan, et al.
European Thyroid Journal|July 2, 2019
The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in NorwayElse Marie Opsahl, Lars Andreas Akslen, Ellen Schlichting, et al.
Molecular Cancer|March 27, 2010
DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment responseEmelyne Dejeux, Jo Anders Rønneberg, Hiroko Solvang, et al.
Annals of Internal Medicine|April 18, 2022
Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus ObservationMikkel Pretorius, Karolina Lundstam, Ansgar Heck, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 3, 2023
Positive Effect of Parathyroidectomy Compared to Observation on BMD in a Randomized Controlled Trial of Mild Primary HyperparathyroidismKarolina Lundstam, Mikkel Pretorius, Jens Bollerslev, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 30, 2020
Effects of Parathyroidectomy on Quality of Life: 10 Years of Data From a Prospective Randomized Controlled Trial on Primary Hyperparathyroidism (the SIPH-Study)Mikkel Pretorius, Karolina Lundstam, Mikael Hellström, et al.
Scientific Reports|January 17, 2026
Low tumoral Trefoil Factor 1 expression relates to aggressive tumor features and poor survival in young women with breast cancerAmalie B Kvamme, Ulrikke Hugaas, Anna K M Sæle, et al.
Pageof 5